Dmitry Martynenko
Direttore/Membro del Consiglio presso Novicol International Holding, Inc.
Provenienza dei contatti di primo grado di Dmitry Martynenko
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Novicol International Holding, Inc.
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Dmitry Martynenko tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Immunethep SA
Immunethep SA BiotechnologyHealth Technology Immunethep SA develops biological products. It specializes in anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company was founded by Pedro Madureira and Bruno Santos and is headquartered in Cantanhede, Portugal. | Biotechnology | Director/Board Member | |
Bsim Therapeutics Ltd. | Director/Board Member | ||
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Aids Initiative | Corporate Officer/Principal | ||
GENFLOW BIOSCIENCES PLC | Biotechnology | Founder | |
BIOHEMP INTERNATIONAL, INC. | Pharmaceuticals: Major | Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin | |
Institut Supérieur des Affaires | College/University | Masters Business Admin | |
Renovaro Biosciences Denmark ApS
Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
RENOVARO INC. | Biotechnology | Chief Executive Officer | |
Dandrit Corp. Pte Ltd. | Chief Executive Officer | ||
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
University of Grenoble | College/University | Doctorate Degree | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL. | Pharmaceuticals: Major | President |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Francia | 6 |
Danimarca | 3 |
Portogallo | 3 |
Regno Unito | 3 |
Settori
Health Technology | 17 |
Consumer Services | 5 |
Miscellaneous | 2 |
Finance | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 16 |
Chief Executive Officer | 8 |
Corporate Officer/Principal | 6 |
Masters Business Admin | 3 |
President | 3 |
Contatti più connessi
Insiders | |
---|---|
Eric Jean Marie Leire | 28 |
- Borsa valori
- Insiders
- Dmitry Martynenko
- Connessioni Società